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Introduction
One of the key factors influencing the success rate of assisted 
reproductive technology (ART) is the quality of the oocytes. 
Through its development inside the follicle, oocyte is sur-
rounded by somatic follicular cells – granulosa cells that pro-
liferate during follicle growth and differentiation. With the 
development of the antral and pre-ovulation follicles, granu-
losa cells differentiate into mural cells surrounding the 
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follicle wall and cumulus cells (CCs) surrounding the 
oocyte.1,2 CCs are in close contact with the oocyte, together 
forming the cumulus–oocyte complex (COC) – a part of the 
microenvironment surrounding the developing oocyte.3–6 
Morphological assessment of the oocyte, commonly used 
during ART, is not always a good predictor of successful fer-
tilization and the developmental capacity of the ensuing 
zygote.1,7 Identification of specific genes or other biological 
components of the microenvironment surrounding each 
oocyte could potentially enable more accurate distinguishing 
between high- and low-quality oocytes, which could in turn 
enhance the success rate of the assisted reproduction 
procedures.8
Anti-Müllerian hormone (AMH) is a glycoprotein 
growth factor secreted by the granulosa cells.9 The normal 
expression pattern of AMH implies that it is present at low 
levels in the primary follicles, followed by gradual growth 
up to maximum in the large pre-antral and small antral fol-
licles, followed by decline as the growth of the follicle con-
tinues.10 Based on this expression pattern, serum AMH was 
suggested to reflect the number of early growing follicles as 
its concentration declines with the decline in a pool of 
developing follicles.11,12 Previous studies have investigated 
AMH gene expression levels in granulosa cells, along with 
its correlation with the oocyte quality, but the obtained 
results were inconsistent and contradictory.13–16 Studies 
have also shown that AMH gene expression levels in CCs 
correlate with the concentration of AMH in the correspond-
ing follicular fluid (FF).14
As with other members of the large transforming growth 
factor beta (TGF-β) family, AMH signals through two 
related transmembrane serine–threonine kinase receptors: 
type 1 (anti-Müllerian hormone receptor type 1 (AMHR1)) 
and type 2 (anti-Müllerian hormone receptor type 2 
(AMHR2)).17 AMHR2 is a ligand-specific receptor and is 
expressed in the Müllerian duct mesenchymal cells and 
gonads in both sexes. Its expression colocalizes with AMH 
gene expression levels in granulosa cells and the specific 
patterns of their gene expressions have important roles in 
follicle development and its functions.17,18 AMHR2 was 
found to be a crucial factor for AMH signalling in AMHR2-
deficient mice.19 Moreover, correlation between gene expres-
sion levels of AMHR2 and AMH in granulosa cells has been 
previously demonstrated.20
The specific pattern of AMH expression in CCs, together 
with follicle-stimulating hormone (FSH), has a role in regu-
lating the quantity of growing follicles as well as in the selec-
tion of the dominant follicle.21 The action of FSH occurs 
through its binding to the follicle-stimulating hormone 
receptor (FSHR), which is localized on the surface of the 
granulosa cells.22 Oestrogen secretion from granulosa cells 
stimulated by FSH causes an increase in the number of 
FSHR sites on the membrane. However, the exact mecha-
nism that explains the interaction between FSH and FSHR 
leading to the activation of different signalling pathways in 
steroidogenesis is still unknown.
Studies across species reported that androgen receptor 
(AR) is expressed in the ovary, uterus and breast in females.23 
In the ovary, AR is expressed in follicular theca and granu-
losa cells as well as in the oocyte.24 Studies on knockout 
mouse models have shown that androgens, via AR, have an 
important role in female fertility, influencing growth and 
development of the follicles as well as ovulation.23–25
A few studies have found connection between gene 
expression of AR, AMH and FSHR in CCs.14,16 Expression 
of the AR gene in the primate ovary CCs is positively associ-
ated with mitosis and negatively with apoptosis in granulosa 
cells, and it is therefore highly expressed in healthy folli-
cles.26 FSHR gene expression levels are also positively cor-
related with AMH gene expression levels in granulosa cells, 
pointing to the existence of a sensitive balance between 
AMH and FSH inside the follicle.27 Grøndahl et al.14 showed 
that the expression of all these genes (AMH, AMHR2, FSHR 
and AR) is higher in follicles that were evaluated as healthy.
This study investigated the expression profiles of the 
AMH gene and its respective receptors (AMHR2, FSHR and 
AR) in the CCs of large antral follicles from healthy women 
undergoing the ART procedure. The aim of this study was to 
compare the studied expression profiles with the morpho-
logical characterization of oocytes from the same COC. The 
correlation between expression levels of these genes and the 
oocyte’s morphological quality during assisted reproduction 
is examined, as well as potential correlation with the mor-
phological characteristics of the zygotes and embryos and 
with the outcome of the ART procedure.
Materials and methods
Subjects
A total of 129 CCs and 35 FF samples were included in the 
study, taken from 58 patients undergoing assisted reproduc-
tion at the Department for Human Reproduction of the Clinic 
of Obstetrics and Gynaecology, Clinical Hospital Centre 
Rijeka, Croatia. The sample size was calculated by the 
OpenEpi calculator using the calculation for comparing two 
means. For smaller sample sizes, the confidence interval was 
adjusted. The study protocol was approved by the ethics 
committee of the Clinical Hospital Centre Rijeka, and writ-
ten consent was obtained from all patients included. Patients 
were principally undergoing the intracytoplasmic sperm 
injection (ICSI) procedure as a result of infertility caused by 
the male factor. All women included in the study were 
healthy normally ovulatory, with body mass indexes between 
18 and 28 kg/m2 and ages between 28 and 45. The patients 
included in the study were undergoing different ovarian 
stimulation protocols during the ART procedure: 32 patients 
underwent the modified natural cycle, 23 patients received 
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gonadotropin-releasing hormone (GnRH) antagonist and 3 
patients received GnRH agonist. Human chorion gonadotro-
phin (hCG; 5000 IU i.m.) was applied to all patients 34–36 h 
prior to the oocyte aspiration.
CCs and FF collection
Each follicle from the patients included was aspirated sepa-
rately under transvaginal ultrasound guidance. Its content 
was examined, and the COC was isolated. CCs were 
removed from the oocyte enzymatically with hyaluronidase, 
centrifuged at 200×g for 5 min and then immediately sub-
jected to RNA extraction. Oocytes were cultivated sepa-
rately. FFs were only included in the study if: they were 
from aspirated follicles in which COC belonging to the 
same follicle was identified, their volume was greater than 
1 mL and they did not contain visible traces of blood. The 
obtained FFs were centrifuged at 500×g for 15 min, ali-
quoted and frozen at −20°C for later analysis. In this way, 
we were able to investigate the oocyte, CCs and FFs origi-
nating from a single follicle.
Gene expression analysis
Total RNA was extracted using an RNeasy Micro Isolation 
kit (Qiagen). cDNA was synthesized using a High Capacity 
DNA Reverse Transcription Kit (Applied Biosystems). Purity 
and concentration of RNA and cDNA were determined spec-
trophotometrically and fluorometrically (Qubit fluorometer; 
Thermo Fisher Scientific and BioDrop DUO; BioDrop). 
AMH, AMHR2, FSHR and AR gene expression level analy-
ses were conducted on a real-time polymerase chain reaction 
(RT-PCR) device (LightCycler 96 System; Roche). According 
to the literature, normalization was performed with two dif-
ferent controls genes (glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) and β-actin genes).28 TaqMan technology 
assays (TaqMan Gene Expression Assays; Applied 
Biosystems) were used to analyse gene expression levels of 
all tested genes: AMH (assay ID: Hs01006984_g1), AMHR2 
(assay ID: hs00179718_m1), FSHR (assay ID: hs00174865_
m1) and AR (assay ID: hs00171172_m1), as well as endoge-
nous controls: GAPDH (assay ID: Hs03929097_g1) and 
β-actin (assay ID: Hs99999903_m1). Relative gene expres-
sion levels were calculated using the delta–delta Ct method 
(relative to the levels of the control genes) using the software 
of the RT-PCR device (LightCycler 96 Software, Version 
1.1.0.1320; Roche).
FF AMH concentrations
Concentrations of AMH in FFs were measured by enzyme-
linked immunosorbent assay (AMH Gen II ELISA; 
Beckman-Coulter). AMH concentrations in a sample were 
calculated based on the calibrators’ absorbance and calibra-
tion curve.
Morphological assessment of oocytes, zygotes 
and embryos
Oocytes were assessed for morphological quality immedi-
ately before and during the ICSI procedure. The ICSI proce-
dure was performed 3–6 h after oocyte retrieval, using 
metaphase II (MII) oocytes only. Zygotes and embryos were 
morphologically assessed 16–18 h and 64–66 h after fertili-
zation, respectively. According to the previously described 
characteristics, oocytes, zygotes and embryos were sepa-
rated into those with optimal and suboptimal morphology 
(Table 1).3,7 The morphological assessment was performed 
by three embryologists from the Department for Human 
Reproduction of the Clinic of Obstetrics and Gynaecology, 
Clinical Hospital Centre Rijeka, Croatia.
ART outcome
ART outcome was determined by measuring the level of 
serum βhCG 21 days after the embryo transfer. Values higher 
than 100 IJ/L were considered to demonstrate pregnancy and 
were denoted as positive ART outcome.
Statistical analysis
Cross-analysis of gene expression levels between morpho-
logically differently rated oocytes, zygotes and embryos was 
conducted using parametric or nonparametric statistical tests 
depending on the data characteristics (size, distribution, scal-
ing etc.). REST 2009 Software (Relative Expression 
Software Tool V2.0.13; Qiagen) was used to examine differ-
ences in gene expression levels between morphologically 
differentially assessed oocytes, zygotes and embryos, as well 
as between oocytes with different ART procedure outcomes. 
To analyse statistical differences between FF AMH concen-
trations in morphologically differentially graded oocytes, 
zygotes and embryos, the Mann–Whitney nonparametric test 
was used. To analyse statistical correlation between FF AMH 
concentration and gene expression levels of AMH, AMHR2, 
FSHR and AR, as well as to analyse correlations between the 
investigated genes’ expression levels, nonparametric 
Kendall’s tau and Spearman’s rank order tests were used. 
Student’s t-test was applied to determine statistical differ-
ences between different data groups. All statistical proce-
dures were run using Statistica Version 12 (StatSoft).
Results
Expression of both AMH and AR mRNA in CCs surrounding 
morphologically optimal oocytes were statistically signifi-
cantly lower than in morphologically suboptimal oocytes 
(2−ΔΔCt(AMH) = 1.703; p = 0.011 and 2−ΔΔCt(AR) = 1.530; 
p = 0.008) (Table 2).
There was no significant difference in AMH or AR mRNA 
expression in CCs surrounding oocytes that developed to 
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zygotes and embryos, based on their morphology. No signifi-
cant differences were found in AMHR2 or FSHR mRNA 
expression levels among different morphological groups of 
oocytes, zygotes and embryos. None of the investigated gene 
expression levels showed statistically significant differences 
with regard to ART outcome (Table 2).
The concentration of FF AMH did not differ significantly 
between different morphological groups of oocytes, zygotes 
and embryos, or between different ART outcomes (p = 0.082, 
p = 0.230, p = 0.486 and p = 0.724, respectively) (Table 3). 
There are no correlation between FF AMH concentration 
and mRNA expression levels of the AMH, AMHR2, FSHR 
or AR genes in associated CCs (p = 0.195, p = 0.809, p = 0.461 
and p = 0.240, respectively).
Correlations between mRNA expression levels of the 
genes investigated are summarized in Table 4. Statistically 
significant correlation was found between AMH and FSHR 
mRNA expression levels (p < 0.001) as well as between 
AMH and AR mRNA expression levels (p = 0.001) and 
AMHR2 and FSHR (p < 0.001), AMHR2 and AR (p < 0.001) 
and FSHR and AR (p < 0.001) mRNA expression levels.
Discussion
The aim of this study was to analyse the expression patterns 
of biologically interconnected genes in COCs isolated from 
large antral follicles of healthy women during the ART proce-
dure. We found that morphologically suboptimal oocytes had 
statistically significantly higher levels of AMH and AR gene 
expression in their associated CCs (2−ΔΔCt(AMH) = 1.703; 
p = 0.011 and 2−ΔΔCt(AR) = 1.530; p = 0.008; Table 2). Up until 
now, AMH was normally considered to correlate with ovarian 
reserve and the primordial follicle recruitment, as well as 
with oocyte quality and ART procedure outcome.29–32 Our 
results are consistent with the studies which found negative 
correlations between AMH gene expression in CCs and 
oocyte maturity, as well as elevated AMH gene expression in 
CCs of immature follicles.14,16
The specific expression pattern of AMH (low levels in pri-
mary follicles, gradual growth in pre-antral and early antral 
follicles followed by a decrease as the follicle continues to 
grow) implies its importance for regulating the quantity of 
growing follicles as well as for selection of the dominate 
follicle.10,21,33,34 According to the previous studies, AMH 
might be one of the factors involved in determining the respon-
siveness of the follicle to FSH during cyclic recruitment and 
resumption of follicle growth and development.17,18 It is there-
fore possible that AMH levels are used for regulating the 
growth of those follicles which contain oocytes of the ade-
quate fertilization potential. In ART procedures, as a result of 
hormonal stimulation, larger numbers of follicles develop, 
while in the natural cycle their development would have 
already stopped. Furthermore, higher expression of AMH in 
CCs surrounding morphologically poorly rated oocytes 
might imply that those oocytes have difficulties with resum-
ing meiosis. Indeed, AMH acting as a meiosis inhibitor has 
previously been observed in rat oocytes.35 Grøndahl et al.14 
found that, in spite of a decrease in AMH expression in 
maturing follicles, there is still a certain amount of AMH 
expression left in the CCs of pre-ovulation follicles. This 
could indicate that AMH plays a yet unclarified role in oocyte 
maturation during the final stages of folliculogenesis.
AR and its expression in CCs were previously positively 
associated with follicular health in primates.26,36 Grøndahl 
et al.14 have also found higher AR expression levels in CCs of 
immature follicles, as well as positive correlation between 
AMH and AR expression levels, which is consistent with our 
results. The role of AR and androgens in general in follicular 
development is still insufficiently explained. Walters et al.23,37 
found that even a short-term increase in ovarian androgen lev-
els can lead to permanent negative effects on follicular devel-
opment in mouse models and that AR might have a role in 
unexplained anovulation. Negative correlation between AR 
expression in CCs and oocyte morphology can be explained 
by its direct effect on gene transcription and its indirect effect 
on cytoplasmic proteins involved in signal transmission. This 
Table 1. Morphological assessment of the oocytes, zygotes and embryos.
Morphology Characteristics N
Oocyte Optimal Mature MII oocyte (presence of 1PB in the PV) 107
Suboptimal MI oocyte (absence of GV in the cytoplasm and 1PB in the PV), PI oocyte (presence of GV 
in the cytoplasm) or atretic/degenerated oocyte (breakdown of ZP or dark vacuolated 
cytoplasm)
22
Zygote Optimal Adequate morphology, size and arrangement of the two PN, adequate arrangement of 4–6 
NPBs and presence of the Halo effect
73
Suboptimal Inadequate morphology, size, arrangement and/or number of the PN, inadequate number, 
size and arrangement of NPBs or absence of the Halo effect
44
Embryo Optimal ⩾7 blastomeres and <20% fragmentation 29
Suboptimal <7 blastomeres and <20% fragmentation or ⩾7 blastomeres and >20% fragmentation 73
MII: metaphase II; 1PB: first polar body; PV: perivitelline space; MI: metaphase I; GV: germinal vesicle; PI: prophase I; ZP: zona pellucida; PN: pronucleus; 
NPB: nucleolar precursor body.
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can lead to disruption in communication between oocyte and 
CCs and consequently to poor oocyte quality.38,39
Our results suggest that gene expression levels of AMH 
and AR in CCs were not associated with morphological 
graduation of zygotes or embryos, which might point to a 
relationship of AMH and AR with oocyte maturity, but not 
with its fertilization potential.
There was no correlation between AMHR2 and FSHR 
gene expression levels in CC and morphological grade of 
oocytes, zygotes and embryos, or with ART procedure out-
come. Moreover, no association was found with AMH FF 
concentration either. Previously conducted studies found 
similar results, although there are some inconsistencies 
among the reported results that can be explained by differ-
ences in presenting ART outcomes, as well as by the myr-
iad of factors that can impact on fertilization, besides 
oocyte quality (e.g. sperm quality or ART procedure, 
patient selection).16,40–42 The observed lack of correlation 
between FF AMH concentration and expression of the 
investigated genes in CCs from the same follicles might 
arise from the fact that the follicles studied were in the pre-
ovulation phase (diameter 20 mm or more), by which time 
FF AMH levels have already decreased. Perhaps, more 
accurate results would be obtained using more precise 
measurement techniques, such as mass spectrometry.
Results regarding correlations between the relative expres-
sion levels of the genes reported here (Table 4) have been 
previously reported; however, that study was conducted on 
smaller, early antral follicles.20 Nevertheless, we found no 
correlation between AMH and AMHR2 gene expression lev-
els (r = 0.14; p = 0.107; Table 4). Similar results were reported 
by Catteau-Jonard et al.,13 while Rice et al.43 reported very 
low AMHR2 expression in pre-antral follicles, at the time 
when AMH expression reaches its maximum. To date, 
AMHR2, as a type II receptor, has been considered essential 
for AMH signalling.17,18 It is thought that all members of 
TGF-β superfamily, as well as AMH, signal through two 
types of receptors: type I and II. Together they form the serine–
threonine kinase receptor complex, composed of ligand-spe-
cific type II receptors and more general type I receptors.18,44 
Table 2. AMH, AMHR2, FSHR and AR mRNA ΔCt differences between morphological groups of oocytes, zygotes and embryos as well 
as between different ART outcomes.
Samples Morphology N AMH AMHR2 FSHR AR
ΔCt (average) p ΔCt (average) p ΔCt (average) P ΔCt (average) p
Oocyte Optimal 107 5.589 0.011* 8.058 0.765 11.125 0.109 5.465 0.008*
Suboptimal 22 4.821 7.982 10.749 4.851
Zygote Optimal 73 5.665 0.117 8.040 0.725 11.077 0.753 5.308 0.177
Suboptimal 44 5.277 8.115 11.135 5.566
Embryo Optimal 29 5.424 0.624 8.237 0.629 10.954 0.386 5.393 0.917
Suboptimal 73 5.570 8.117 11.140 5.416
ART outcome Positive 11 5.457 0.997 8.231 0.553 11.234 0.551 5.535 0.543
Negative 118 5.458 8.028 11.045 5.344
AMH: anti-Müllerian hormone; AMHR2: anti-Müllerian hormone receptor type 2; FSHR: follicle-stimulating hormone receptor; AR: androgen receptor; 
mRNA: messenger RNA; ART: assisted reproductive technology.
*p ⩽ 0.05.
Table 3. FF AMH concentration differences between morphological groups of oocytes, zygotes and embryos as well as between 
different ART outcomes.
Samples Morphology N FF AMH
Concentration (ng/mL) P
Oocyte Optimal 31 12.045 0.082
Suboptimal 4 21.516
Zygote Optimal 22 11.195 0.230
Suboptimal 10 15.208
Embryo Optimal 11 11.717 0.486
Suboptimal 18 11.996
ART outcome Positive 5 12.066 0.724
Negative 30 13.304
FF: follicular fluid; AMH: anti-Müllerian hormone; ART: assisted reproductive technology.
Statistical significance p ⩽ 0.05.
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However, the results described here might suggest a further 
investigation of the importance of the AMHR2 as well as of 
the type I receptors in the AMH signalling pathway. The other 
assessed correlations (Table 4) are consistent with previously 
reported results from similar studies.13,14,20
No significant differences in FF AMH concentration, or 
in AMH, AMHR2, FSHR and AR expression levels in CCs, 
were found between younger (aged < 35) and older 
(aged ⩾ 35) patients. However, despite the fact that the serum 
AMH concentration decreases with age, it is not the result of 
concentration, or the expression of AMH in each individual 
follicle, but the overall number of follicles that is greater in 
younger patients. Although the serum AMH level might be 
considered as an indicator of ovarian reserve, as it reflects 
the size of the developing follicles pool, it is not associated 
with the AMH level in individual follicles, or with the qual-
ity of the associated oocytes.45–47
The potential limitation of the study is the heterogeneity 
of the study population in terms of age and applied ovarian 
stimulation protocol. It has been previously shown that gene 
expressions can be affected by age and controlled ovarian 
stimulation.48,49 Nevertheless, our results showed no differ-
ences in CC gene expressions regarding patients’ age or 
ovarian stimulation protocol (p > 0.05; data not shown).
In this study, negative association was reported for the 
first time between AMH and AR gene expression levels in 
CCs isolated from healthy women during the ART procedure 
and the morphological quality of the oocyte from the same 
COC. This research reinforces the importance of the COC, 
namely as a means of communication between an oocyte and 
its microenvironment, for oocyte development is a prerequi-
site for successful fertilization and quality embryo forma-
tion. Further research, with larger groups of patients with 
stricter inclusion criteria, of the oocyte’s microenvironment, 
such as CCs’ gene expression and FF content profiling, are 
needed in order to clarify its importance for the oocyte matu-
ration and fertilization potential.
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